Jorge Santos da Silva, CEO, Director at MoonLake Immunotherapeutics, holds 2.92M shares in MoonLake Immunotherapeutics (Ticker: MLTX). Most recently, Jorge Santos da Silva Sold 150,000 shares of MoonLake Immunotherapeutics on Apr 14, 2026 for an estimated value of $2.75M.
What is the percentage of profitable transactions made by Jorge Santos da Silva?
The percentage of profitable transactions made by Jorge Santos da Silva is 50%.
What is the average return per transaction made by Jorge Santos da Silva?
The average return per transaction made by Jorge Santos da Silva is -1.80%.
What stocks does Jorge Santos da Silva hold?
Jorge Santos da Silva holds: MLTX stocks.
What was Jorge Santos da Silva’s latest transaction?
Jorge Santos da Silva latest transaction was an Informative Sell of $2.75M.
What was Jorge Santos da Silva's most profitable transaction?
Jorge Santos da Silva’s most profitable transaction was an Informative Sell of MLTX stock on April 14, 2026. The return on the trade was 10.90%.
What is Jorge Santos da Silva's role in MoonLake Immunotherapeutics?
Jorge Santos da Silva's role in MoonLake Immunotherapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.